The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
According to the estimates by IMARC Group, the global bioinformatics market is expected to grow at a CAGR of XX% during 2022-2027.
Significant advancements in the field of biotechnology, along with the growing demand for nucleic acid and protein sequencing for proteomics and drug discovery, represents some of the key drivers for the global bioinformatics market.
The increasing investments by IT companies for the development of bioinformatics solutions, coupled with the rising preferences for personalized medicines, represent some of the key trends in the global bioinformatics market.
Sudden outbreak of the COVID-19 pandemic has led to the increase in the demand of bioinformatics for the development of healthcare-based software solutions, thereby positively influencing the market growth.
On the basis of the product and service, the market has been bifurcated into knowledge management tools, bioinformatics platforms, and bioinformatics services. Currently, bioinformatics platforms hold the majority of the total market share.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
The key companies in the global bioinformatics market are ABM Industries, Agilent Technologies, Biomax Informatics, Data4Cure Inc., Dnastar Inc., Illumina Inc., Life Technologies, PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, Sophia Genetics SA, Thermo Fisher Scientific Inc., Waters Corp, WuXi Nextcode Genomics, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at